drugset / Trial / NCT02203487
Safety, Tolerability and Pharmacokinetics of Increasing Repeated Doses of BIIF 1149 BS in Healthy Male Volunteers
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of the present study was to obtain information about the safety and tolerability of BIIF 1149 BS after repeated dosing and to obtain preliminary pharmacokinetics data (steady state and accumulation factor)
Timeline
- Start
- 1999-11
- Primary completion
- 2000-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FIGOPITANT | Small molecule | 5 mg | Oral |
| Subject | FIGOPITANT | Small molecule | 10 mg | Oral |
| Subject | FIGOPITANT | Small molecule | 25 mg | Oral |
| Subject | FIGOPITANT | Small molecule | 40 mg | Oral |
Indications
No indication recorded.